ArticleDrug design, development and therapy2026

Radiosensitivity Enhancement by Combined Treatment of Nimotuzumab and Celecoxib on Nasopharyngeal Carcinoma Cells [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.